WuXi PharmaTech files $120M IPO on NYSE - FierceBiotech - Biotechnology Articles, Biotech Industry News, FDA Approval News

WuXi PharmaTech files $120M IPO on NYSE - FierceBiotech - Biotechnology Articles, Biotech Industry News, FDA Approval News: "Putting an end to the rumors, China's WuXi PharmaTech, the country's largest CRO, has announced plans for a $120 million IPO on the New York Stock Exchange. The U.S. offering was spurred in part by the fact that most of the company's revenue is coming from American companies. Founded six years ago, WuXi has been growing fast as China takes a central place in the drug development world."